Review Bundle 06 2023
|
Instruction |
|
Time |
|
Tasks |
Pediatric Cancer Syndromes
Objectives
- Recognize clinical features of hereditary cancer syndromes with pediatric manifestations.
- Recognize the conditions under which a pediatric cancer patient should be referred to Clinical Genetics.
- Provide education on hereditary cancer syndromes with pediatric manifestations to parents, patients and providers in age appropriate manner.
Pediatric Cancer Syndromes: Counseling Issues
Objectives
- Identify genetic counseling and testing issues associated with pediatric hereditary cancer syndromes.
- Apply appropriate germline genetic testing strategies for hereditary pediatric cancer syndromes.
Hereditary Hematologic Cancer Syndromes
Objectives
- Recognize the basics of hematologic malignancies.
- Identify the currently known hereditary hematologic malignancy syndromes.
- Distinguish the unique needs for genetic testing in the setting of hematologic malignancies.
The modules in this bundle will discuss possible barriers and biases which may impact patient care (i.e., race, ethnicity, language, gender identity/orientation, age, socioeconomic status, attitudes, feelings, or other characteristics).
Accreditation Details for Bundle 6:
TARGET AUDIENCE: Physicians, Physician Assistants, Genetic Counselors, Master's or PhD in Genetics or Advanced Practice Nurses, and Geneticists.
ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
CREDIT DESIGNATION: City of Hope designates this enduring material for a maximum of 3.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
The following credit type(s) are being offered for this course:
• AMA PRA Category 1 Credit™ 3.5
The following may apply AMA PRA Category 1 Credit™ for license renewal:
Registered Nurses: Nurses may report up to 3.5 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.
Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.
Junne Kamihara, MD, PhD
Attending Physician; Instructor of Pediatrics, Harvard Medical School
Dana-Farber/Boston Children's Cancer and Blood Disorders Center; Harvard Medical School
Dr. Kamihara received her medical degree from Harvard Medical School and her PhD in genetics from MIT. She completed her pediatric residency training at Boston Children’s Hospital/Boston Medical Center and her fellowship in pediatric hematology/oncology at the Dana-Farber Cancer Institute and Boston Children’s Hospital. She is currently an attending physician in the Jimmy Fund Clinic. Her research and clinical interests focus on pediatric cancer predisposition syndromes.
Dr. Kamihara serves as an expert for the Department of Hematology-Oncology for Boston Children's Hospital Precision Medicine Service. For more information about the Precision Medicine Service please visit bostonchildrens.org/precisionmed.
Sandra Dreike, MS, CGC
Manager, Genetic Counselor
City of Hope
SANDRA DREIKE, MS, CGC is a licensed board-certified genetic counselor who specializes in cancer genetics. Sandra joined the City of Hope Division of Clinical Cancer Genomics in 2019, where she provides genetic counseling and cancer genetic risk assessments as a Senior Genetic Counselor. She received her Master of Science degree is Genetic Counseling from University of California, Irvine and her bachelor’s degree in Biology from California Polytechnic State University, San Luis Obispo. She previously practiced as a genetic counselor in Honolulu, HI where she specialized in cancer genetics and general pediatric and adult genetics. In addition to patient care she is a faculty member of the City of Hope Intensive Course and Clinical Cancer Genomics Community of Practice, and research. Sandra is a member of the National Society of Genetic Counselors (NSGC) and Southern California Genetic Counselors (SCGC).
Jane Churpek, MD
Assistant Professor, Section of Hematology/Oncology and Center for Clinical Cancer Genetics
University of Wisconsin-Madison
JANE CHURPEK, MD, MS, is an Assistant Professor in the Division of Hematology, Medical Oncology and Palliative Care within the Department of Medicine at the University of Wisconsin - Madison. She is a board-certified hematologist and oncologist who focuses on the care of adults with low blood counts due to acquired and inherited causes, including clonal hematopoiesis, myelodysplastic syndrome, and inherited bone marrow failure syndromes. She also specializes in the diagnosis and management of patients and their families with hereditary cancer predisposition syndromes. Dr. Churpek’s research focuses on identifying inherited genetic factors that cause increased risk of cancer and bone marrow disorders, especially among understudied tumors and blood disorders. Her goal is to understand who is at increased risk and how specific exposures increase or decrease risk. She aims to utilize this information to optimize early detection, treatment, and, ultimately, prevention of cancer and bone marrow disorders. Dr. Churpek has contributed to the understanding of several novel hereditary blood cancer predisposition syndromes and the role of inherited predisposition in exposure-associated cancers such as therapy-related leukemia and mesothelioma. She is a member of the American Society of Clinical Oncology, the American Society of Hematology, and the American Society of Human Genetics, and she is the recipient of an American Society for Clinical Investigation Young Physician-Scientist Award.